Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05621369 · ClinicalTrials.gov registry record
Psorcast Mobile Study
A clinical trial of Psoriasis and Psoriatic Arthritis, sponsored by Sage Bionetworks.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05621369 is a study of Psoriasis and Psoriatic Arthritis that is actively recruiting participants, run by Sage Bionetworks. The registered enrollment target is 1,000 participants, above the 481-participant average among 125 other Psoriasis trials with a reported enrollment target (108% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05621369, a study of Psoriasis and Psoriatic Arthritis, is actively recruiting participants, sponsored by Sage Bionetworks.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.
Conditions Studied
Interventions
- BEHAVIORAL Participant self-assessment surveys
- BEHAVIORAL Psoriasis Draw
- BEHAVIORAL Psoriasis Area Photo
- BEHAVIORAL Finger and Toe Photos
- BEHAVIORAL Digital Jar Open
Study Locations (1)
Washington
- Sage Bionetworks - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2027-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05621369
The ClinicalTrials.gov registry entry for NCT05621369 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 481-participant average among 125 other Psoriasis trials with a reported enrollment target (108% higher). The listed sponsor is Sage Bionetworks, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Psoriasis appearing as the primary indexed condition, and to 5 interventions - of which Participant self-assessment surveys is the first listed.
NCT05621369 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05621369 about?
NCT05621369 is a clinical study titled "Psorcast Mobile Study". The purpose of this study is to understand variation in the symptoms of psoriasis and psoriatic arthritis using simple, scalable smartphone-based measurements. This study uses an iPhone app to record these symptoms through questionnaires and sensors.
What is the current status of trial NCT05621369?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-01-01. Estimated completion is 2027-01-31.
What conditions does trial NCT05621369 study?
This clinical trial studies the following conditions: Psoriasis, Psoriatic Arthritis, Plaque Psoriasis, Joint Pain, Rheumatologic Disease.
What interventions are being tested in trial NCT05621369?
The interventions under investigation include: Participant self-assessment surveys (BEHAVIORAL), Psoriasis Draw (BEHAVIORAL), Psoriasis Area Photo (BEHAVIORAL), Finger and Toe Photos (BEHAVIORAL), Digital Jar Open (BEHAVIORAL).
Who is sponsoring clinical trial NCT05621369?
This trial is sponsored by Sage Bionetworks, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05621369 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
RECRUITING · NA
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
Duobrii in Combination With Biologics
RECRUITING · Phase 4
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.